Source: Annual Congress 2004 - Exercise and gas exchange
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Newall, L. Harper, C. O. Savage, S. L. Hill (Birmingham, Edgbaston, Birmingham, United Kingdom). Physiological characteristics in patients with microscopic polyangitis (MPA) and wegener‘s granulomatosis (WG). Eur Respir J 2004; 24: Suppl. 48, 2073

Member's Comments

No comment yet.

Related content which might interest you: Granulomatosis with polyangiitis (Wegener&s) Source: Eur Respir Mon 2011; 54: 1-14 Year: 2011 Coexistent granulomatosis with polyangiitis (Wegener‘s) and Crohn disease: A clinicopathologic description of cases Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012 Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Wegener‘s granulomatosis (WG) limited to the lungs Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004 New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Wegener's granulomatosis (WG) - clinical features and response to treatment in 18 cases Source: Eur Respir J 2002; 20: Suppl. 38, 64s Year: 2002 Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases Source: International Congress 2014 – ILDs 6 Year: 2014 Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) Source: Eur Respir J 2016; 48: 1429-1441 Year: 2016 Microscopic polyangiitis and granulomatosis with polyangiitis Source: Eur Respir Monogr 2019; 86: 153-172 Year: 2019 An atypical presentation of granulomatosis with polyangiitis (GPA) with pituitary involvement Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020 Year: 2020 Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69 Year: 2005 Alveolar haemorrhage syndromes Source: Eur Respir Mon 2011; 54: 15-31 Year: 2011 Clinical presentation of Wegener‘s granulomatosis (WG) in relation to age and sex Source: Annual Congress 2007 - Granulomatous lung diseases including sarcoidosis Year: 2007 ANCA-negative eosinophilic granulomatosis with polyangiitis (EGPA) relatead to sirolimus-eluting stent Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA) Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Biologics for eosinophilic granulomatosis with polyangiitis Source: Short video statement 2020 Year: 2020 Effectiveness of rituximab (RTX) therapy in recurrent granulomatosis with polyangiitis (GPA) Source: International Congress 2016 – New and old therapies for chronic lung diseases Year: 2016